The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
Immunization is one of the most successful public health interventions in history. National immunization programs reach >100 million infants every year and have averted globally two to three million deaths every year since the launch of the Expanded Program for Immunization (EPI) in 1974 , whilst the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save ~1 million lives per year. Furthermore, great advances in discovering and financing new vaccines provides a great opportunity for countries to further reduce burden of disease such as human papillomavirus (HPV). Despite these successes, 1.5 million children still die each year of vaccine-preventable diseases, many of them in low-income countries, as immunization programs there face unprecedented challenges.
Since 2010, the Clinton Health Access Initiative (CHAI) has worked to save lives and reduce the burden from vaccine preventable diseases by improving access to immunization services in resource-limited setting by strengthening national immunization programs and by leveraging its experience in-country to improve the global immunization ecosystem. CHAI is pursuing six complementary strategic goals:
CHAI's vaccine program very closely supports the national immunization programs in 11 focus countries - Cameroon, Ethiopia, India, Indonesia, Kenya, Lao PDR, Lesotho, Nigeria, Tanzania, Uganda and Vietnam- and also engages with global stakeholders such as Gavi, WHO and UNICEF to inform global policies and practices.
In Gavi-supported countries, Gavi often bears over 70% of immunization costs - a large fraction of this consisting of subsidies for new vaccines introduced with Gavi support. Thus, one of the key concerns is whether countries that transition from Gavi support will be able to sustain their immunization schedule and coverage rates when they are fully self-financing. Countries approaching or currently in transition thus need to think strategically about their financial planning, which new vaccines to introduce, and to plan and mobilize domestic and external resources early to ensure those new vaccine costs can be sustained post-transition.
 Calculated based on UNICEF antigen price list, for an intermediate country having introduced Penta, PCV and Rota with Gavi support, but paying for traditional vaccines, operational costs and co-financing requirements. Cross-checked with APR reports from Gavi countries, financial section. Note that this share can be substantially higher – e.g. Ethiopia reported that Gavi was paying 91% of its immunization costs in 2012.
We are seeking a Senior Associate to join the Global Vaccines Delivery team and support CHAI's work in helping focus countries (Kenya, Lao PDR, Vietnam, Indonesia, Nigeria) navigate and plan for Gavi transition.
We are seeking a motivated individual with superior analytic, problem solving, and cross-cultural communication skills. The candidate should excel at presenting data and messages powerfully through written documents and presentations; working collaboratively in a fast-paced, multi-cultural environment; and functioning independently with minimal guidance, with a deep personal commitment to enhancing immunization outcomes.
The successful candidate will provide strategic guidance to transitioning countries with significant autonomy and develop thought leadership in one or more of the following areas:
Key responsibilities for this role include, but are not limited to: